Table 2.
Results of multivariate Cox proportional-hazards regression analyzing the effect of baseline variables on in-hospital death in all patients with COVID-19
Mode | HR (95%CI) | P |
---|---|---|
Not adjusted CD4+T level, lower vs. higher | 13.659 (3.235–57.671) | < 0.001 |
Mode 1 | ||
CD4+T cell level, lower vs. higher | 14.182 (1.884–106.786) | 0.010 |
Sex, male vs. female | 1.383 (0.561–3.406) | 0.481 |
Age, per 1 year | 1.093 (1.052–1.135) | < 0.001 |
Temperature, per 1 °C | 0.777 (0.445–1.354) | 0.372 |
Mode 2 | ||
CD4+T cell level, lower vs. higher | 13.631 (3.190–58.243) | < 0.001 |
Hypertension, yes vs. no | 5.823 (2.595–13.070) | < 0.001 |
Diabetes, yes vs. no | 0.824 (0.322–2.113) | 0.688 |
Shortness of breath, yes vs. no | 7.848 (2.942–20.934) | < 0.001 |
Mode 3 | ||
CD4+T cell level, lower vs. higher | 8.170 (1.877–35.566) | 0.005 |
WBC, per 1×109/L | 1.294 (1.193–1.404) | < 0.001 |
PLT, per 1×109/L | 0.992 (0.987–0.997) | 0.003 |
Cr, per 1 umol/L | 1.002 (0.995–1.009) | 0.576 |
Mode 4 | ||
CD4+T cell level, lower vs. higher | 10.644 (2.439–46.458) | 0.002 |
Hs-CRP, per 1 mg/L | 0.989 (0.974–1.005) | 0.193 |
PCT, per 1 ng/ml | 1.017 (0.925–1.118) | 0.724 |
D-dimer, per 1 mg/L | 1.028 (1.018–1.038) | < 0.001 |
Mode 5 | ||
CD4+T cell level, lower vs. higher | 13.650 (1.976–94.279) | 0.008 |
CD8+T cell level, lower vs. higher | 3.159 (0.853–11.707) | 0.085 |
CD4/CD8 ratio, per 1 unit | 1.422 (1.105–1.830) | 0.006 |
LYM level, lower vs. higher | 0.996 (0.306–3.243) | 0.994 |
Mode 6 | ||
CD4+T cell level, lower vs. higher | 7.656 (1.610–36.396) | 0.010 |
Age, per 1 year | 1.074 (1.034–1.115) | < 0.001 |
Hypertension, yes vs. no | 2.031 (0.766–5.386) | 0.154 |
Shortness of breath, yes vs. no | 3.435 (1.167–10.114) | 0.025 |
WBC, per 1×109/L | 1.224 (1.097–1.366) | < 0.001 |
PLT, per 1× 109/L | 0.996 (0.991–1.001) | 0.149 |
D-dimer, per 1 mg/L | 0.997 (0.992–1.002) | 0.207 |
CD4/CD8 ratio, per 1 unit | 1.106 (0.793–1.542) | 0.552 |
Abbreviations: WBC white blood cell, PLT platelet, Cr creatinine, Hs-CRP hypersensitive C-reactive protein, PCT procalcitonin, LYM lymphocyte